Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DORIS VOY KAN QUON

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1578589271
CMS profile
297740
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$226,862.23

214 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 5 of 5; records 201–214 of 214 matching records. This page contains 14 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DORIS VOY KAN QUON

NPI 1578589271 · CMS profile ID 297740

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology

LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 5; records 201–214 of 214 matching records. This page contains 14 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DORIS VOY KAN QUON, NPI 1578589271, CMS profile ID 297740. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–214 of 214 matching records. This page contains 14 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). DORIS VOY KAN QUON, NPI 1578589271, CMS profile ID 297740. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–214 of 214 matching records. This page contains 14 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
DORIS VOY KAN QUON, NPI 1578589271, CMS profile ID 297740, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 5; records 201–214 of 214 matching records. This page contains 14 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

214 matching records · $226,862.23 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 214 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–214 of 214.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $27.7701/29/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706573093 CMS
Novo Nordisk Inc $6,075.0001/29/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706574137 CMS
Novo Nordisk Inc $21.6501/29/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706659071 CMS
Clovis Oncology, Inc. $15.7201/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688686805 CMS
Genentech USA, Inc. $214.5801/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681179109 CMS
Genentech USA, Inc. $5,280.0001/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681291725 CMS
Genentech USA, Inc. $128.0001/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681315033 CMS
Genentech USA, Inc. $949.9101/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681315035 CMS
Array BioPharma Inc. $24.5901/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700973281 CMS
BIOVERATIV THERAPEUTICS INC. $353.3301/14/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694271023 CMS
BIOVERATIV THERAPEUTICS INC. $7.0001/14/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694307421 CMS
Shire North American Group Inc $11,200.0001/08/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 637899791 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.5501/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697381251 CMS
PFIZER INC. $20.6301/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672630939 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $226,862.23 214
PY2020 $90,905.75 91
PY2021 $105,472.93 143
PY2022 $183,243.94 231
PY2023 $281,959.74 291
PY2024 $320,376.86 276
PY2025 $252,825.46 221

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $11,776.00 1
PY2025 Principal investigator $68,008.58 17
PY2024 Principal investigator $114,372.92 34
PY2023 Recipient $2,750.00 7
PY2023 Principal investigator $37,805.79 21
PY2022 Recipient $8,190.00 4
PY2022 Principal investigator $49,912.90 6
PY2021 Recipient $250.00 1
PY2021 Principal investigator $63,451.55 14
PY2020 Recipient $4,503.36 6
PY2020 Principal investigator $35,874.90 17
PY2019 Recipient $2,870.91 7
PY2019 Principal investigator $189,684.85 30

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

18 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 BioMarin Pharmaceutical Inc. $777.40 11/17/2025 Non-covered Recipient Entity
Orthopaedic Hospital
BMN 270-401 No dispute reported 06/30/2026 1248579955
Principal investigator 1 Genentech, Inc. $16,430.00 10/24/2025 Non-covered Recipient Entity
ORTHOPAEDIC INSTITUTE FOR CHILDREN
A STUDY TO EVALUATE JOINT HEALTH PHYSICAL ACTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENT No dispute reported 06/30/2026 1211635998
Principal investigator 1 HEMA Biologics, LLC $1,500.00 10/17/2025 Non-covered Recipient Entity
ORTHOPAEDIC INSTITUTE FOR CHILDRENORTHOPAEDIC HEMOPHILIA TREATMENT CENTER
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT No dispute reported 06/30/2026 1211421449
Principal investigator 1 BioMarin Pharmaceutical Inc. $778.70 09/18/2025 Non-covered Recipient Entity
Orthopaedic Hospital
BMN 270-401 No dispute reported 06/30/2026 1248579953
Principal investigator 1 Genentech, Inc. $9,711.00 08/28/2025 Non-covered Recipient Entity
ORTHOPAEDIC INSTITUTE FOR CHILDREN
A STUDY TO EVALUATE JOINT HEALTH PHYSICAL ACTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENT No dispute reported 06/30/2026 1211635994
Principal investigator 1 PFIZER INC. $6,143.66 08/22/2025 Non-covered Recipient Entity
Orthopaedic Hospital dba Orthopaedic Hemophilia Treatment Center
A PHASE 1B OPENLABEL NONRANDOMIZED STUDY TO ASSESS THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF MARSTACIMAB TREATMENT FOLLOWING THE DISCONTINUATION OF EMICIZUMAB THERAPY IN ADOLESCENT AND ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS No dispute reported 06/30/2026 1228766565
Principal investigator 1 BioMarin Pharmaceutical Inc. $1,037.40 08/14/2025 Non-covered Recipient Entity
Orthopaedic Hospital
BMN 270-401 No dispute reported 06/30/2026 1248579951
Principal investigator 1 PFIZER INC. $6,143.66 08/02/2025 Non-covered Recipient Entity
Orthopaedic Hospital dba Orthopaedic Hemophilia Treatment Center
A PHASE 1B OPENLABEL NONRANDOMIZED STUDY TO ASSESS THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF MARSTACIMAB TREATMENT FOLLOWING THE DISCONTINUATION OF EMICIZUMAB THERAPY IN ADOLESCENT AND ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS No dispute reported 06/30/2026 1228767551
Principal investigator 1 PFIZER INC. $10,128.00 06/26/2025 Non-covered Recipient Entity
Orthopaedic Hospital dba Orthopaedic Hemophilia Treatment Center
A PHASE 1B OPENLABEL NONRANDOMIZED STUDY TO ASSESS THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF MARSTACIMAB TREATMENT FOLLOWING THE DISCONTINUATION OF EMICIZUMAB THERAPY IN ADOLESCENT AND ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS No dispute reported 06/30/2026 1228776875
Principal investigator 1 BioMarin Pharmaceutical Inc. $1,556.10 05/30/2025 Non-covered Recipient Entity
Orthopaedic Hospital
BMN 270-401 No dispute reported 06/30/2026 1248579949
Principal investigator 1 CSL Behring $18.00 05/27/2025 Non-covered Recipient Entity
Orthopaedic Institute for Children
An Extension Study Assessing the Long-term Safety and Efficacy of Etranacogene Dezaparvovec (CSL222) Previously Administered to Adult Male Subjects With Hemophilia B No dispute reported 06/30/2026 1252666131
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $650.00 05/19/2025 Non-covered Recipient Entity
The Luskin Oic Medical Pavilion And Ambulatory Surgery Center
BAY 949027, HEM-POWR Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A No dispute reported 06/30/2026 1225408846
Principal investigator 1 BioMarin Pharmaceutical Inc. $2,298.40 04/16/2025 Non-covered Recipient Entity
Orthopaedic Hospital
BMN 270-401 No dispute reported 06/30/2026 1248579947
Recipient F. Hoffmann-La Roche AG $11,776.00 03/31/2025 Covered Recipient Physician A literature review of major surgery experience with emicizumab in people with hemophilia A without factor VIII inhibitors No dispute reported 06/30/2026 1211535512
Principal investigator 1 BioMarin Pharmaceutical Inc. $4,596.80 03/14/2025 Non-covered Recipient Entity
Orthopaedic Hospital
BMN 270-401 No dispute reported 06/30/2026 1248579945
Principal investigator 1 HEMA Biologics, LLC $3,000.00 02/26/2025 Non-covered Recipient Entity
ORTHOPAEDIC HOSPITAL
ATHN 16 No dispute reported 06/30/2026 1211421429
Principal investigator 1 SANOFI US SERVICES INC. $1,683.36 02/18/2025 Non-covered Recipient Entity
Orthopaedic Institute For Children
OBS effectiveness of Efanesoctocog alfa prophylaxis on joint health in previously treated HEMOA patients No dispute reported 06/30/2026 1226108103
Principal investigator 1 BioMarin Pharmaceutical Inc. $1,556.10 02/14/2025 Non-covered Recipient Entity
Orthopaedic Hospital
BMN 270-401 No dispute reported 06/30/2026 1248579943